CTX-130 (as an anti-CD70 CAR-T) has been tested in the COBALT-LYM (T-cell lymphoma) and COBALT-RCC (advanced clear cell renal cell carcinoma) studies. The gene discussed is CD70; the disease is renal cell carcinoma.